Business Segments · Depreciation
Life Sciences and Emerging Growth Businesses — Depreciation
Corning Life Sciences and Emerging Growth Businesses — Depreciation decreased by 10.3% to $26M in Q1 2026 compared to the prior quarter.
Analysis
StatementSegment
CategoryEfficiency
SignalContext dependent
VolatilityStable
First reportedQ1 2025
Last reportedQ1 2026May 1, 2026
Rolls up toD&A
How to read this metric
An increase often correlates with recent capital investments, while a decrease may signal aging infrastructure or reduced asset utilization.
Detailed definition
This metric represents the systematic allocation of the cost of tangible assets used within the Life Sciences and Emergi...
Peer comparison
Comparable to depreciation and amortization charges in capital-intensive manufacturing segments.
Metric ID:
glw_segment_life_sciences_and_emerging_growth_businesses_depreciationHistorical Data
2 periods
| Q1 '25 | Q1 '26 | |
|---|---|---|
| Value | $29M | $26M |
| QoQ Change | — | -10.3% |
| YoY Change | — | -10.3% |
Range$26M – $29M
Avg YoY Growth-10.3%
Median YoY Growth-10.3%
Similar Metrics at Other Companies
Frequently Asked Questions
- What is Corning's life sciences and emerging growth businesses — depreciation?
- Corning (GLW) reported life sciences and emerging growth businesses — depreciation of $26M in Q1 2026.
- What does life sciences and emerging growth businesses — depreciation mean?
- The non-cash expense representing the wear and tear of assets in the Life Sciences and Emerging Growth segment.